Aktive Positionen von Mark Carlton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cerevance, Inc.
 Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2016 | - |
| Gründer | 01.01.2016 | - |
Karriereverlauf von Mark Carlton
Ehemalige bekannte Positionen von Mark Carlton
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Paradigm Therapeutics Ltd.
 Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Direktor/Vorstandsmitglied | 01.01.1999 | 12.03.2007 |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.1999 | 12.03.2007 |
Ausbildung von Mark Carlton
| University of Cambridge | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Paradigm Therapeutics Ltd.
Paradigm Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Paradigm Therapeutics Ltd. discovers and develops drugs. The genomics-based drug discovery company uses research methods including model mouse genetics, bioinformatics and molecular biology to identify genes that serve as drug targets. The company has launched a subsidiary research center in Singapore. The company was founded in 1999 by Aparicio Samuel and Mark Carlton and is headquartered in Cambridge, UK. | Health Technology |
Cerevance, Inc.
Cerevance, Inc. Medical SpecialtiesHealth Technology Cerevance, Inc. provides pharmaceutical services. The firm discovers new treatments for central nervous system diseases. Its platform enables to profile specific brain cell types including both neurons and glial cells in mature human brain tissue. The company was founded by Bradley A. Margus and Mark Carlton in 2016 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Mark Carlton
- Erfahrung
